Print Page

Letters to Healthcare Providers
 
European Union: PRAC concludes eye condition NAION is a very rare side effect of semaglutide medicines Ozempic, Rybelsus and Wegovy (Letter to Healthcare Professionals)
 
 
 
Attachment:
  1. NAION  
Related Information:
The United Kingdom: Semaglutide (Wegovy, Ozempic and Rybelsus): risk of Non-arte... Posted 2026-02-06
European Union: PRAC concludes eye condition NAION is a very rare side effect of... Posted 2025-06-07
European Union: Medicines containing semaglutide: PRAC investigating risk of rar... Posted 2025-01-18
 
back